T

Terns Pharmaceuticals
D

TERN

52.810
USD
-0.07
(-0.13%)
مفتوح الان
حجم التداول
516,918
الربح لكل سهم
-1
العائد الربحي
-
P/E
-52
حجم السوق
5,745,631,619
أصول ذات صلة الأخبار المقالات

العنوان: Terns Pharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases. Its product candidates include TERN-701, TERN-601, TERN-501 and TERN-800.